The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 15, 2025
Filed:
Nov. 21, 2022
Applicant:
Ocular Therapeutix, Inc., Bedford, MA (US);
Inventors:
Charles D. Blizzard, Nashua, NH (US);
Arthur Driscoll, Reading, MA (US);
Rami El-Hayek, Norwood, MA (US);
Michael Goldstein, Cambridge, MA (US);
Joseph Iacona, Somerville, MA (US);
Peter Jarrett, Burlington, MA (US);
Timothy S. Jarrett, Boston, MA (US);
Erica Kahn, Cambridge, MA (US);
Zachary Lattrell, Newburyport, MA (US);
Assignee:
OCULAR THERAPEUTIX, INC., Bedford, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 31/4427 (2006.01); A61K 31/4439 (2006.01); A61K 47/34 (2017.01); A61P 27/02 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0051 (2013.01); A61K 9/06 (2013.01); A61K 31/4427 (2013.01); A61K 31/4439 (2013.01); A61K 47/34 (2013.01); A61P 27/02 (2018.01); A61K 9/0019 (2013.01); A61K 45/06 (2013.01);
Abstract
The invention relates to a sustained release biodegradable ocular implant containing a tyrosine kinase inhibitor dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.